Cargando…

Comparative evaluation of the potential impact of rotavirus versus hpv vaccination in GAVI-eligible countries: A preliminary analysis focused on the relative disease burden

BACKGROUND: Immunization policymakers at global and local levels need to establish priorities among new vaccines competing for limited resources. However, comparison of the potential impact of single vaccination programs is challenging, primarily due to the limited number of vaccine analyses as well...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sun-Young, Sweet, Steven, Chang, Joshua, Goldie, Sue J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129299/ https://www.ncbi.nlm.nih.gov/pubmed/21679420 http://dx.doi.org/10.1186/1471-2334-11-174

Ejemplares similares

Health and economic impact of rotavirus vaccination in GAVI-eligible countries
por: Kim, Sun-Young, et al.
Publicado: (2010)

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country
por: Burger, Emily A., et al.
Publicado: (2018)

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2021)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Gavi HPV Programs: Application to Implementation
por: Hanson, Celina M., et al.
Publicado: (2015)

Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2019)

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
por: Bilcke, Joke, et al.
Publicado: (2019)

The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study
Publicado: (2019)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

Cost-effectiveness of Rotavirus vaccination in Vietnam
por: Kim, Sun-Young, et al.
Publicado: (2009)

Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects
por: Botwright, Siobhan, et al.
Publicado: (2017)

Challenges to sustainable immunization systems in Gavi transitioning countries
por: Cernuschi, Tania, et al.
Publicado: (2018)

Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
por: Li, Xiao, et al.
Publicado: (2020)

Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction
por: Soble, Adam, et al.
Publicado: (2020)

Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
por: Kamya, Carol, et al.
Publicado: (2016)

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries
por: Marijam, Alen, et al.
Publicado: (2022)

Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program
por: Faisal-Cury, Alexandre, et al.
Publicado: (2020)

The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models
por: Baral, Ranju, et al.
Publicado: (2020)

Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
por: Löwensteyn, Yvette N., et al.
Publicado: (2021)

Assessing vaccine introduction and uptake timelines in Gavi-supported countries: are introduction timelines accelerating across vaccine delivery platforms?
por: Luthra, Karuna, et al.
Publicado: (2021)

Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
por: Löwensteyn, Yvette N., et al.
Publicado: (2021)

Exploring the influence of the Global Fund and the GAVI Alliance on health systems in conflict-affected countries
por: Patel, Preeti, et al.
Publicado: (2015)

Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries
por: Saxenian, Helen, et al.
Publicado: (2015)

Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study
por: Birger, Ruthie, et al.
Publicado: (2022)

Evaluating Country Performance After Transitioning From Gavi Assistance: An Applied Synthetic Control Analysis
por: Kolesar, Robert John, et al.
Publicado: (2023)

The GAVI Alliance and the ‘Gates approach’ to health system strengthening
por: Storeng, Katerini T.
Publicado: (2014)

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
por: Steele, A.D., et al.
Publicado: (2019)

Effectiveness of Monovalent Rotavirus Vaccine in Mozambique, a Country with a High Burden of Chronic Malnutrition
por: Chissaque, Assucênio, et al.
Publicado: (2022)

Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy
por: Prosser, Wendy, et al.
Publicado: (2022)

Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study
por: Donken, Robine, et al.
Publicado: (2018)

How to evaluate the implementation of complex health programmes in low-income settings: the approach of the Gavi Full Country Evaluations
por: Soi, Caroline, et al.
Publicado: (2020)

Has Gavi lived up to its promise? Quasi-experimental evidence on country immunisation rates and child mortality
por: Jaupart, Pascal, et al.
Publicado: (2019)

Advancing Immunization Coverage and Equity: A Structured Synthesis of Pro-Equity Strategies in 61 Gavi-Supported Countries
por: Ivanova, Vesela, et al.
Publicado: (2023)

GAVI supply chain strategy people and practice evidence review
por: Steele, Pamela
Publicado: (2014)

Worldwide burden of cancer attributable to HPV by site, country and HPV type
por: de Martel, Catherine, et al.
Publicado: (2017)

Post-GAVI sustainability of the Haemophilus influenzae type b vaccine program: The potential role of economic evaluation
por: Le, Phuc, et al.
Publicado: (2016)

Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance’s 2018 Vaccine Investment Strategy: report from an expert survey
por: Malarski, Maya, et al.
Publicado: (2019)

Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years
por: Troeger, Christopher, et al.
Publicado: (2018)

Rotaviruses and Rotavirus Vaccines
por: Donato, Celeste M., et al.
Publicado: (2021)

Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999–2014)
por: Gandhi, Gian
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qhmke87691kddjrba6qq8t2dl3